10 research outputs found

    1‑Aminoanthracene Transduction into Liposomes Driven by Odorant-Binding Protein Proximity

    No full text
    In this work, the anchorage of pig odorant binding protein (OBP-I) into liposomal membrane was promoted by the fusion of OBP-I with the anchor SP-DS3 peptide and with the (GQ)<sub>20</sub> spacer. The presence of the (GQ)<sub>20</sub> spacer in the construct confers flexibility to the protein and increases the distance between the OBP binding site and the liposomal surface. The engineered proteins, OBP::SP-DS3 and OBP::(GQ)<sub>20</sub>::SP-DS3, were produced in <i>Escherichia coli</i> BL21­(DE3) and characterized by circular dichroism spectroscopy and MALDI-TOF. The functionalization of liposomes with the OBP proteins was performed through ethanol injection, and similar liposomal anchorage (âˆŧ92–97%) was found for both OBP constructs. The effect of OBPs’ proximity to the liposomes membrane on 1-aminoanthracene (1-AMA, model ligand) transduction was evaluated by measuring the amount of 1-AMA transduced into liposomes by fluorescence spectroscopy. While protein flexibility, given by the presence of the (GQ)<sub>20</sub> spacer, seems to influence the binding efficiency, âˆŧ45% for OBP::(GQ)<sub>20</sub>::SP-DS3 and âˆŧ29% for OBP::SP-DS3, the distance between the proteins’ binding site and the liposomal membrane determines their ability to transduce the 1-AMA into the liposomes (âˆŧ23% for OBP::SP-DS3 and âˆŧ19% for OBP::(GQ)<sub>20</sub>::SP-DS3). The anchorage capacity and proximity effect were confirmed by an experimental control where the wild-type (wt) OBP was added to the liposomes, resulting in low 1-AMA transduction (âˆŧ3.5%) and low binding to OBPwt (âˆŧ9%). These findings evidence the effect of anchorage, carrier protein’s flexibility, and proximity as key features for the entrapment of molecules into the liposomal membrane. The developed OBP-based devices are thus promising anchorage systems for the capture and storage of odors with potential applications in textile and cosmetic industries

    Phosphorylated Silk Fibroin Matrix for Methotrexate Release

    No full text
    Silk-based matrix was produced for delivery of a model anticancer drug, methotrexate (MTX). The calculation of net charge of silk fibroin and MTX was performed to better understand the electrostatic interactions during matrix formation upon casting. Silk fibroin films were cast at pH 7.2 and pH 3.5. Protein kinase A was used to prepare phosphorylated silk fibroin. The phosphorylation content of matrix was controlled by mixing at specific ratios the phosphorylated and unphosphorylated solutions. <i>In vitro</i> release profiling data suggest that the observed interactions are mainly structural and not electrostatical. The release of MTX is facilitated by use of proteolytic enzymes and higher pHs. The elevated β-sheet content and crystallinity of the acidified-cast fibroin solution seem not to favor drug retention. All the acquired data underline the prevalence of structural interactions over electrostatical interactions between methotrexate and silk fibroin

    Lithium calix[4]arenes: structural studies and use in the ring opening polymerization of cyclic esters

    Get PDF
    We have structurally characterized a number of lithiated calix[4]arenes, where the bridge in the calix[4]arene is thia (–S–, LS H4), sulfinyl (–SO–, LSOH4), sulfonyl (–SO2–, LSO2H4), dimethyleneoxa (–CH2OCH2–, LCOCH4) or methylene (–CH2–, LH4). In the case of L4SH4, interaction with LiOtBu led to the isolation of the complex [Li8(L4S)2(THF)4]5THF (15THF), whilst similar interaction of L4SOH4 led to the isolation of [Li6(L4SOH)2(THF)2]5(THF) (25THF).Interestingly,themixedsulfinyl/sulfonylcomplexes[Li8(calix[4]arene(SO)(SO2)SO1.68)2)2(THF)6]8(THF)(38THF)andLi5Na(LSO/3SO2H)2(THF)5]7.5(THF)(47.5(THF)havealsobeencharacterized.InteractionofLiOtBuwithLSO2H4andLCOCH4afforded[Li5L4SO2(OH)(THF)4]2THF(55THF). Interestingly, the mixed sulfinyl/sulfonyl complexes [Li8(calix[4] arene(SO)(SO2) SO1.68)2)2(THF)6]8(THF) (38THF) and Li5Na(LSO/3SO2H)2(THF)5]7.5(THF) (47.5(THF) have also been characterized. Interaction of LiOtBu with LSO2H4 and LCOCH4 afforded [Li5L4SO2(OH)(THF)4]2THF (52THF) and [Li6(LCOC)2(HOtBu)2]0.78THF1.22hexane (60.78THF1.22hexane), respectively. In the case of LH4, reaction with LiOtBu in THF afforded a monoclinic polymorph [LH2Li2(thf)(OH2)2]3THF (73THF) of a known triclinic form of the complex, whilst reaction of the de-butylated analogue of LH4, namely de-BuLH4, afforded a polymeric chain structure {[Li5(de-BuL)(OH)(NCMe)3]2MeCN}n (82MeCN). For comparative catalytic studies, the complex [Li6(LPr)2(H2O)2]hexane (9 hexane), where LPr2H2 Âŧ 1,3-di-n-propyloxycalix[4]areneH2, was also prepared. The molecular crystal structures of 1–9 are reported, and their ability to act as catalysts for the ring opening (co-)/polymerization (ROP) of the cyclic esters 3-caprolactone, d-valerolactone, and rac-lactide has been investigated. In most of the cases, complex 6 outperformed the other systems, allowing for higher conversions and/or greated polymer Mn

    Insights on the Mechanism of Formation of Protein Microspheres in a Biphasic System

    No full text
    Microspheres of bovine serum albumin (BSA) and silk fibroin are produced by applying ultrasound in a biphasic system consisting of an aqueous protein solution and an organic solvent. The protein microspheres are dispersed in an aqueous media where the protein remains at the interface covering the organic solvent. This only occurs when high shear forces are applied that induce changes to force the protein to the interface. Fourier transform infrared results indicate a large increase in the content of the β-sheet during the formation of silk fibroin microspheres. Molecular dynamics simulations show a clear adaption on the 3D structure of BSA when stabilized at the interface, without major changes in secondary structure. Further studies demonstrate that high water content, oil solvents, and larger peptides with separated and clear hydrophobic and hydrophilic areas lead to more stable and smaller spheres. This is the first time that these results are presented. We also present herein the rationale to produce tailored protein microspheres with a controlled size, controlled charge, and increased stability

    Radical conversion of (1) terephthalic acid to (2) 2-hydroxyterephthalic acid [16].

    No full text
    <p>Radical conversion of (1) terephthalic acid to (2) 2-hydroxyterephthalic acid [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0197537#pone.0197537.ref016" target="_blank">16</a>].</p

    Normalized extraction efficiencies (%) for ultrasound-assisted extractions: (A) extraction without pretreatment, (B) extraction with one boiling water pretreatment and (C) extraction with two following boiling water pretreatments.

    No full text
    <p>Normalized extraction efficiencies (%) for ultrasound-assisted extractions: (A) extraction without pretreatment, (B) extraction with one boiling water pretreatment and (C) extraction with two following boiling water pretreatments.</p

    (A) Relative increase [%] of (+)-pinoresinol measured by LC-ESI-TOF after extraction B (extraction with one boiling water pretreatment) and C (extraction with two following boiling water pretreatments) using an input power of 200 or 400 W with a 15 mm probe depth (B) Dimerization reaction of coniferyl alcohol radicals generated by ultrasound induced radical formation to (+)-pinoresinol; the control consisted on the extraction without ultrasound.

    No full text
    <p>(A) Relative increase [%] of (+)-pinoresinol measured by LC-ESI-TOF after extraction B (extraction with one boiling water pretreatment) and C (extraction with two following boiling water pretreatments) using an input power of 200 or 400 W with a 15 mm probe depth (B) Dimerization reaction of coniferyl alcohol radicals generated by ultrasound induced radical formation to (+)-pinoresinol; the control consisted on the extraction without ultrasound.</p

    presentation_1_Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Macrophages and a Novel Target to Treat Diseases With Macrophage Imbalances.PDF

    No full text
    <p>If misregulated, macrophage (MĪ•)–T cell interactions can drive chronic inflammation thereby causing diseases, such as rheumatoid arthritis (RA). We report that in a proinflammatory environment, granulocyte-MĪ• (GM-CSF)- and MĪ• colony-stimulating factor (M-CSF)-dependent MĪ•s have dichotomous effects on T cell activity. While GM-CSF-dependent MĪ•s show a highly stimulatory activity typical for M1 MĪ•s, M-CSF-dependent MĪ•s, marked by folate receptor β (FRβ), adopt an immunosuppressive M2 phenotype. We find the latter to be caused by the purinergic pathway that directs release of extracellular ATP and its conversion to immunosuppressive adenosine by co-expressed CD39 and CD73. Since we observed a misbalance between immunosuppressive and immunostimulatory MĪ•s in human and murine arthritic joints, we devised a new strategy for RA treatment based on targeted delivery of a novel methotrexate (MTX) formulation to the immunosuppressive FRβ<sup>+</sup>CD39<sup>+</sup>CD73<sup>+</sup> MĪ•s, which boosts adenosine production and curtails the dominance of proinflammatory MĪ•s. In contrast to untargeted MTX, this approach leads to potent alleviation of inflammation in the murine arthritis model. In conclusion, we define the MĪ• extracellular purine metabolism as a novel checkpoint in MĪ• cell fate decision-making and an attractive target to control pathological MĪ•s in immune-mediated diseases.</p

    video_1_Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Macrophages and a Novel Target to Treat Diseases With Macrophage Imbalances.mov

    No full text
    <p>If misregulated, macrophage (MĪ•)–T cell interactions can drive chronic inflammation thereby causing diseases, such as rheumatoid arthritis (RA). We report that in a proinflammatory environment, granulocyte-MĪ• (GM-CSF)- and MĪ• colony-stimulating factor (M-CSF)-dependent MĪ•s have dichotomous effects on T cell activity. While GM-CSF-dependent MĪ•s show a highly stimulatory activity typical for M1 MĪ•s, M-CSF-dependent MĪ•s, marked by folate receptor β (FRβ), adopt an immunosuppressive M2 phenotype. We find the latter to be caused by the purinergic pathway that directs release of extracellular ATP and its conversion to immunosuppressive adenosine by co-expressed CD39 and CD73. Since we observed a misbalance between immunosuppressive and immunostimulatory MĪ•s in human and murine arthritic joints, we devised a new strategy for RA treatment based on targeted delivery of a novel methotrexate (MTX) formulation to the immunosuppressive FRβ<sup>+</sup>CD39<sup>+</sup>CD73<sup>+</sup> MĪ•s, which boosts adenosine production and curtails the dominance of proinflammatory MĪ•s. In contrast to untargeted MTX, this approach leads to potent alleviation of inflammation in the murine arthritis model. In conclusion, we define the MĪ• extracellular purine metabolism as a novel checkpoint in MĪ• cell fate decision-making and an attractive target to control pathological MĪ•s in immune-mediated diseases.</p

    video_2_Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Macrophages and a Novel Target to Treat Diseases With Macrophage Imbalances.mov

    No full text
    <p>If misregulated, macrophage (MĪ•)–T cell interactions can drive chronic inflammation thereby causing diseases, such as rheumatoid arthritis (RA). We report that in a proinflammatory environment, granulocyte-MĪ• (GM-CSF)- and MĪ• colony-stimulating factor (M-CSF)-dependent MĪ•s have dichotomous effects on T cell activity. While GM-CSF-dependent MĪ•s show a highly stimulatory activity typical for M1 MĪ•s, M-CSF-dependent MĪ•s, marked by folate receptor β (FRβ), adopt an immunosuppressive M2 phenotype. We find the latter to be caused by the purinergic pathway that directs release of extracellular ATP and its conversion to immunosuppressive adenosine by co-expressed CD39 and CD73. Since we observed a misbalance between immunosuppressive and immunostimulatory MĪ•s in human and murine arthritic joints, we devised a new strategy for RA treatment based on targeted delivery of a novel methotrexate (MTX) formulation to the immunosuppressive FRβ<sup>+</sup>CD39<sup>+</sup>CD73<sup>+</sup> MĪ•s, which boosts adenosine production and curtails the dominance of proinflammatory MĪ•s. In contrast to untargeted MTX, this approach leads to potent alleviation of inflammation in the murine arthritis model. In conclusion, we define the MĪ• extracellular purine metabolism as a novel checkpoint in MĪ• cell fate decision-making and an attractive target to control pathological MĪ•s in immune-mediated diseases.</p
    corecore